This will be the key player here. Exciting times ahead.
CAESAREA, Israel, July 10, 2014 /PRNewswire/ -- LabStyle Innovations Corp. (OTCQB:DRIO), developer of the Dario™ Diabetes Management Solution, today announced the appointment of Professor Richard B. Stone as an independent member of its Board of Directors.
Prof. Stone brings over forty-five years of legal and business experience to LabStyle as an entrepreneur, venture capitalist public, company officer and director, and legal and corporate governance expert. He currently serves on the board of directors of multiple technology companies, including Powermat, Espro-Accoustiguide Group, Wellsense Technologies, NanoX Imaging and Check-Cap. Among his other public company experiences, Prof. Stone cofounded Lev Pharmaceuticals, Inc. which was sold to ViroPharma in 2008 for nearly $450 million in upfront consideration.
Prof. Stone is presently and has since 1974 served as a professor at Columbia Law School, specializing in tax law and business planning, and previously served as an Assistant Solicitor General of the United States. He also served as Chairman of the Conference of Presidents of Major American Jewish Organizations. He is a graduate of Harvard University and Harvard Law School.
"We are very excited to have someone with Richard's extensive experience and credentials, particularly in the medical and technology industries, join our Board of Directors," said Dr. Oren Fuerst, LabStyle's Chairman of the Board. "As we continue to grow and expand Dario into new markets, Richard will be an incredible asset allowing us to draw on his vast knowledge of law as well as managing and financing companies. In addition, his corporate governance experience will be particularly helpful to us, and we expect that he will be an active member of our independent board committees."
"I'm very excited to be joining the team that has created Dario, which promises to make a notable difference in the lives of people with diabetes," said Prof. Stone. "I believe this innovative technology has amazing potential, and I look forward to playing a direct role in helping LabStyle achieve its operational and corporate goals."
